Approved for clinical trials as boosters in Hong Kong.

Second 500k doses expected in two weeks.

UPDATED 5.31PM | Prices exclude additional charges but sellers must list full sale amount.

The study, however, has not been peer reviewed.

The vaccine will be produced and distributed by a joint venture.

The lab study's implications on real-world protection are still unclear.

The study also shows it enhances cell-based responses.

The group says it is acting in accordance with the law.

The study in Guangdong is pending formal review by experts.

UPDATED 1.03PM | It requires two doses to be administered at a 21-day interval.

The Indian Ocean nation records daily cases in the low hundreds.

Adham Baba describes the recent article by Asia Sentinel as 'baseless'.

Should this be endorsed, it will become China's first approved vaccine for general public use.

COVID-19 | National Institutes of Biotechnology Malaysia has no objections for company to buy China vaccine.